Head, Marketing & Commercial Operations
Harrow
Summary
Owns the promotional review and production operating system for the whole commercial organization: PRC governance, congresses and meetings, print and production, sample and transparency compliance, marketing analytics, martech, and alliance management. Single point of accountability for campaign speed-to-field and promotional compliance across all three franchises.
Job description
Position Summary
Owns the promotional review and production operating system for the whole commercial organization: PRC governance, congresses and meetings, print and production, sample and transparency compliance, marketing analytics, martech, and alliance management. Single point of accountability for campaign speed-to-field and promotional compliance across all three franchises.
Core Responsibilities
- Own PRC governance: SOPs, review calendar, turnaround targets, and audit-ready records.
- Run the enterprise congress and meetings program, a major part of the role, with Marketing and Professional Relations & KOL Development.
- Own print, production, fulfillment, and version control for promotional materials.
- Own the sample program (allocation, PDMA accountability, FDA sample reporting) and HCP transparency reporting through the Lead, Sample Management & Compliance.
- Administer the CRM (Salesforce Life Sciences Cloud), marketing automation, and the digital asset library, with Digital Marketing owning channel strategy and Commercial Enablement & Training driving field adoption.
- Lead marketing analytics (campaign measurement, Google Analytics, ROI analysis, etc.) and reporting built on Microsoft Fabric.
- Oversee alliance management with licensing and supply partners.
- Own the function's budget, vendor contracts, and KPIs; report them in the commercial business review.
- Own the promotional materials systems (Veeva PromoMats, Showpad, and the print fulfillment site) for both branded and compounded (ImprimisRx) portfolios; confirm compounded scope.
Qualifications & Requirements
- Bachelor's degree; 12+ years in pharma or biotech, including 6+ in marketing operations, promotional review, or commercial operations.
- Led a marketing operations and/or commercial operations function at a growth-stage company.
- Deep expertise in promotional review, OPDP rules, and Form FDA 2253 submissions.
- Ran congress, meetings, or speaker-program operations at national scale.
- Experience with PDMA sample compliance and transparency reporting.
- 5+ years leading teams; strong process and SOP design.
- Proficiency with AI platforms such as ChatGPT and Claude, and with Slack.
Preferred Qualifications
- Built a marketing operations and/or commercial operations function at a growth-stage company.
- Salesforce administration or martech ownership.
- Launch experience; eye care experience.
Position Type
Remote (U.S.)
Travel
Approximately 30%
Requirements
- Bachelor's degree
- 12+ years in pharma or biotech
- 6+ years in marketing operations, promotional review, or commercial operations
- Led a marketing operations and/or commercial operations function at a growth-stage company
- Deep expertise in promotional review, OPDP rules, and Form FDA 2253 submissions
- Ran congress, meetings, or speaker-program operations at national scale
- Experience with PDMA sample compliance and transparency reporting
- 5+ years leading teams
- Strong process and SOP design
- Proficiency with AI platforms such as ChatGPT and Claude
- Proficiency with Slack
Company overview
Harrow Health, Inc. (NASDAQ: HROW) is a publicly traded pharmaceutical company headquartered in Nashville, Tennessee, specializing in ophthalmic healthcare solutions. Founded in 2012 and formerly known as Imprimis Pharmaceuticals, the company has established itself as a growing leader in the ophthalmic pharmaceutical market. Harrow operates through multiple subsidiaries including ImprimisRx, its compounding pharmacy business that produces cGMP ophthalmic eye drops and sterile compounded products. The company's core mission focuses on providing affordable and accessible medications while maintaining an unyielding dedication to innovation. Harrow gained significant attention for developing low-cost alternatives to expensive medications, most notably creating a $1 per pill alternative to Daraprim during the Martin Shkreli controversy. The company's business model emphasizes developing inexpensive alternatives to off-patent medicines where single manufacturers charge excessive prices. With a portfolio that includes branded, generic, and compounded ophthalmic medications, Harrow serves healthcare providers and patients across the United States through its FDA-registered outsourcing facilities and nationwide distribution network.